Why the study?
Does oral prednisolone improve renal function in patients with cholesterol embolization following invasive arterial maneuvers?
Does oral prednisolone improve renal function in patients with cholesterol embolization following invasive arterial maneuvers?
Oral prednisolone may be a beneficial treatment for improving renal function in patients with cholesterol embolization following invasive arterial procedures.
Answers are grounded in this paper and cite their sources.
May support prednisolone for renal recovery in post-procedural cholesterol embolization; hypothesis-generating and requires prospective validation.
Cholesterol embolization (CE) is a potentially serious complication associated with invasive arterial maneuvers, in which standard therapy has not been established. We experienced two cases of CE in patients with severe atherosclerosis whose renal function deteriorated within a few months after invasive arterial maneuvers. CE was confirmed either by renal biopsy (case 1) or skin biopsy (case 2). Oral administration of prednisolone at a daily dose of 30 mg (0.4 mg/kg) was effective to improve their renal function. Our observation suggests that corticosteroid therapy may be beneficial in some patients with CE.
No takes yet. Share an insight, caveat, or question.
Koga et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: